Please Wait.....
Report
Europe In-vitro Diagnostics Market Report and Forecast 2024-2032
Market Report I 2023-11-23 I 150 Pages I EMR Inc.
Europe In-vitro Diagnostics Market Report and Forecast 2024-2032
Market Outlook
According to the report by Expert Market Research (EMR), the Europe in-vitro diagnostics market is projected to grow at a CAGR of 4.2% between 2024 and 2032. Aided by the rising prevalence of chronic diseases, aging population, technological advancements in diagnostics, and increased investment in healthcare infrastructure, the market is expected to grow significantly by 2032.
In-vitro diagnostics (IVD) encompasses tests conducted on human specimens like blood or tissue taken from the body. IVD tests facilitate disease detection and management and play an integral role in maintaining overall health, further helping in the prevention, treatment, and management of various diseases. These tests are crucial across a broad spectrum of clinical fields, including infectious diseases, cancer, cardiac diseases, autoimmune diseases, and diabetes.
In-vitro diagnostic (IVD) solutions are provided by a number of leading companies, and they provide quick, accurate findings while lowering cost and complexity. Better diagnosis is made possible by contemporary in-vitro diagnostics (IVDs) for the management and prevention of infectious and chronic diseases. These factors are anticipated to fuel the market expansion.
The rise in chronic diseases such as cancer, heart diseases, and diabetes is a significant factor fuelling the Europe in-vitro diagnostics market growth. The increasingly aging population, who are more susceptible to these diseases, further necessitates the use of IVD tests. This increasing demand is further augmented by the growing consciousness about early diagnosis and preventative healthcare among individuals in Europe.
Technological innovations in diagnostics have also had a significant impact on the Europe in-vitro diagnostics market outlook. The advent of molecular diagnostics, next-generation sequencing, and point-of-care testing has revolutionised the IVD market. These innovative technologies offer faster, more accurate results and aid in personalised treatment plans, thereby improving the overall effectiveness of the healthcare system.
Additionally, the in-vitro diagnostics market is getting a significant push from the growing investment in healthcare infrastructure. Governments across Europe are increasing their healthcare spending, ensuring better access to quality healthcare services, including diagnostic tests. This, in turn, stimulates the market growth.
Further, the growing adoption of point-of-care (POC) diagnostics also contributes to the Europe in-vitro diagnostics market expansion. The shift towards POC testing, which provides immediate results at the patient's location, has been accelerated by the COVID-19 pandemic, which necessitates swift diagnostics and patient management.
Market Segmentation
The market can be divided based on product and services, technology, application, end use, and country.
Market Breakup by Product and Services
- Reagents and Kits
- Instruments
- Software and Services
Market Breakup by Technology
- Immunoassay/Immunochemistry
- Clinical Chemistry
- Molecular Diagnostics
- Haematology
- Microbiology
- Blood Glucose Self-Monitoring
- Coagulation and Haemostasis
- Urinalysis
- Others
Market Breakup by Application
- Infectious Diseases
- Diabetes
- Cardiology
- Oncology
- Autoimmune Diseases
- Nephrology
- Others
Market Breakup by End Use
- Hospitals
- Laboratories
- Homecare
- Others
Market Breakup by Country
- United Kingdom
- Germany
- France
- Italy
- Others
Competitive Landscape
The EMR report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the Europe in-vitro diagnostics market. Some of the major players explored in the report by Expert Market Research are as follows:
- F. Hoffmann-La Roche Ltd
- QIAGEN GmbH
- BioMerieux, Inc
- Siemens Healthineers AG
- ELITechGroup
- Oncgnostics GmbH
- Others
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.
*We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage - Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Europe
7 Opportunities and Challenges in the Market
8 Europe In-Vitro Diagnostics Market Analysis
8.1 Key Industry Highlights
8.2 Europe In-Vitro Diagnostics Historical Market (2018-2023)
8.3 Europe In-Vitro Diagnostics Market Forecast (2024-2032)
8.4 Europe In-Vitro Diagnostics Market by Product and Services
8.4.1 Reagents and Kits
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Instruments
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Software and Services
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.5 Europe In-Vitro Diagnostics Market by Technology
8.5.1 Immunoassay/Immunochemistry
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Clinical Chemistry
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Molecular Diagnostics
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Haematology
8.5.4.1 Historical Trend (2018-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Microbiology
8.5.5.1 Historical Trend (2018-2023)
8.5.5.2 Forecast Trend (2024-2032)
8.5.6 Blood Glucose Self-monitoring
8.5.6.1 Historical Trend (2018-2023)
8.5.6.2 Forecast Trend (2024-2032)
8.5.7 Coagulation and Haemostasis
8.5.7.1 Historical Trend (2018-2023)
8.5.7.2 Forecast Trend (2024-2032)
8.5.8 Urinalysis
8.5.8.1 Historical Trend (2018-2023)
8.5.8.2 Forecast Trend (2024-2032)
8.5.9 Others
8.6 Europe In-Vitro Diagnostics Market by Application
8.6.1 Infectious Diseases
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Diabetes
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Cardiology
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Oncology
8.6.4.1 Historical Trend (2018-2023)
8.6.4.2 Forecast Trend (2024-2032)
8.6.5 Autoimmune Diseases
8.6.5.1 Historical Trend (2018-2023)
8.6.5.2 Forecast Trend (2024-2032)
8.6.6 Nephrology
8.6.6.1 Historical Trend (2018-2023)
8.6.6.2 Forecast Trend (2024-2032)
8.6.7 Others
8.7 Europe In-Vitro Diagnostics Market by End Use
8.7.1 Hospitals
8.7.1.1 Historical Trend (2018-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Laboratories
8.7.2.1 Historical Trend (2018-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 Homecare
8.7.3.1 Historical Trend (2018-2023)
8.7.3.2 Forecast Trend (2024-2032)
8.7.4 Others
8.8 Europe In-Vitro Diagnostics Market by Country
8.8.1 United Kingdom
8.8.2 Germany
8.8.3 France
8.8.4 Italy
8.8.5 Others
9 Regional Analysis
9.1 United Kingdom
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Germany
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
9.3 France
9.3.1 Historical Trend (2018-2023)
9.3.2 Forecast Trend (2024-2032)
9.4 Italy
9.4.1 Historical Trend (2018-2023)
9.4.2 Forecast Trend (2024-2032)
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter's Five Forces Analysis
10.2.1 Supplier's Power
10.2.2 Buyer's Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 F. Hoffmann-La Roche Ltd
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 QIAGEN GmbH
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 BioMerieux, Inc
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Siemens Healthineers AG
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 ELITechGroup
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Oncgnostics GmbH
11.2.6.1 Company Overview
11.2.6.2 Product Portfolio
11.2.6.3 Demographic Reach and Achievements
11.2.6.4 Certifications
11.2.7 Others
12 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Europe In-Vitro Diagnostics Market: Key Industry Highlights, 2018 and 2032
2. Europe In-Vitro Diagnostics Historical Market: Breakup by Product and Services (USD Million), 2018-2023
3. Europe In-Vitro Diagnostics Market Forecast: Breakup by Product and Services (USD Million), 2024-2032
4. Europe In-Vitro Diagnostics Historical Market: Breakup by Technology (USD Million), 2018-2023
5. Europe In-Vitro Diagnostics Market Forecast: Breakup by Technology (USD Million), 2024-2032
6. Europe In-Vitro Diagnostics Historical Market: Breakup by End Use (USD Million), 2018-2023
7. Europe In-Vitro Diagnostics Market Forecast: Breakup by End Use (USD Million), 2024-2032
8. Europe In-Vitro Diagnostics Historical Market: Breakup by Country (USD Million), 2018-2023
9. Europe In-Vitro Diagnostics Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Europe In-Vitro Diagnostics Market Structure.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security